Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2019.6476
Abstract: Importance Hematopoietic cell transplantation (HCT) is a therapeutic strategy in the management of several hematological cancers. Limited data exist on the incidence and predictors of 30-day readmission after HCT. Objective To measure the incidence of… read more here.
Keywords: allo hct; readmission; volume; factors associated ... See more keywords
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.7605
Abstract: Importance The ideal postremission strategy in intermediate-risk acute myeloid leukemia (AML) in first complete remission (CR) has been a matter of debate. Objective To explore the optimal therapy for patients with intermediate-risk AML after first… read more here.
Keywords: consolidation chemotherapy; intermediate risk; consolidation; hct ... See more keywords
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2024.5786
Abstract: Importance Although sharing care with local oncologists after allogeneic hematopoietic cell transplantation (HCT) has been proposed for patients living far from HCT centers, it is not known whether a shared strategy is safe or improves… read more here.
Keywords: oncology; trial; care; hct ... See more keywords
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26723
Abstract: We analyzed a Japanese registry database to elucidate the incidence, risk factors, and outcomes of adenovirus (AdV) disease after autologous and allogeneic hematopoietic cell transplantation (HCT) in contemporary real‐world patients. We evaluated the cumulative incidence… read more here.
Keywords: adv disease; cell; disease; hct ... See more keywords
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26824
Abstract: To enhance protective cytomegalovirus (CMV)‐specific T cells in immunosuppressed recipients of an allogeneic hematopoietic cell transplant (HCT), we evaluated post‐HCT impact of vaccinating healthy HCT donors with Triplex. Triplex is a viral vectored recombinant vaccine… read more here.
Keywords: cell; cmv specific; specific cells; hct ... See more keywords
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Hematology"
DOI: 10.1002/ajh.26870
Abstract: Optimal donor selection is fundamental to successful allogeneic hematopoietic cell transplantation (HCT), and donor age influences survival after both matched unrelated donor (MUD) and haploidentical donor HCT. Though recent studies have shown similar outcomes between… read more here.
Keywords: matched unrelated; haploidentical donor; unrelated donor; hct ... See more keywords
Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain
Sign Up to like & getrecommendations! Published in 2024 at "American Journal of Hematology"
DOI: 10.1002/ajh.27228
Abstract: Allogeneic hematopoietic cell transplantation (HCT) is no longer exclusively for the young. With an aging population, development of non‐intensive remission‐inducing strategies for hematologic malignancies, and novel graft‐versus‐host disease‐prevention platforms, an older population of patients is… read more here.
Keywords: allogeneic hematopoietic; hct; cell transplantation; hematopoietic cell ... See more keywords
Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCT
Sign Up to like & getrecommendations! Published in 2025 at "American Journal of Hematology"
DOI: 10.1002/ajh.70022
Abstract: Complement C5 inhibition can be used to treat hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA) but may impact infectious organism clearance, impeding opsonization and lysis. The infectious risks of eculizumab exposure after hematopoietic cell transplant (HCT)… read more here.
Keywords: infection rates; mortality; hct; eculizumab ... See more keywords
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group.
Sign Up to like & getrecommendations! Published in 2022 at "Hematological oncology"
DOI: 10.1002/hon.3101
Abstract: Fatal cardiac complications can occur from the early to late phases after hematopoietic cell transplantation (HCT). Herein, the Japanese transplant registry database was used to retrospectively analyze health records of 33,791 allogeneic HCT recipients to… read more here.
Keywords: cardiac complications; hct; risk factors; risk ... See more keywords
Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.12570
Abstract: Abstract Background The number of patients undergoing autologous haematopoietic cell transplant (HCT) is growing, but little is known about the factors that predict adverse outcomes. Low muscle mass and obesity are associated with disability and… read more here.
Keywords: obesity; body composition; risk; hct ... See more keywords
Clinical and economic burden of pre‐emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Virology"
DOI: 10.1002/jmv.25574
Abstract: Cytomegalovirus (CMV) infection remains a major complication after allogeneic hematopoietic cell transplantation (allo‐HCT). We conducted a retrospective study to determine the clinical and economic burden of pre‐emptive therapy (PET) for CMV infection in 100 consecutive… read more here.
Keywords: cmv infection; economic burden; allogeneic hematopoietic; infection ... See more keywords